Avalyn Pharma

Avalyn Pharma

Biotechnology Research

Cambridge, Massachusetts 4,073 followers

Targeted therapies for rare lung diseases

About us

Avalyn is a clinical-stage biopharmaceutical company developing inhaled therapies to treat rare respiratory diseases, including idiopathic pulmonary fibrosis and other interstitial lung diseases. Our lead candidate, AP01, is a Phase 2b-ready inhaled formulation of pirfenidone in development for the treatment of pulmonary fibrosis

Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Cambridge, Massachusetts
Type
Privately Held

Locations

Employees at Avalyn Pharma

Updates

Similar pages

Browse jobs

Funding